MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness

J Wesson Ashford¹, Jeffrey E Gold², MaryJane A Huenergardt³, Ronit B A Katz⁴, Susanne E Strand⁵, Joe Bolanos⁵, Christopher J Wheeler⁶, George Perry⁷, Carr J Smith⁸, Lawrence Steinman⁹, Mike Y Chen¹⁰, Jeffrey C Wang¹¹, Clinton B Ashford¹², Walton T Roth¹³, Jauhtai Joseph Cheng¹⁴, Steven Chao¹⁴, Jennifer Jennings¹⁵, Daniel Sipple¹⁶, Vicky Yamamoto¹⁷, Babak Kateb¹⁶, David L Earnest¹⁸

Affiliations

¹ War Related Illness & Injury Study Center, VA Palo Alto Health Care System, Calif; Department of Psychiatry & Behavioral Sciences, Stanford University, Palo Alto, Calif. Electronic address: ashford@stanford.edu.
² World Organization, Watkinsville, Ga.
³ Grass Valley, Calif.
⁴ Stanford University School of Medicine, Palo Alto, Calif.
⁵ Society for Brain Mapping & Therapeutics (SBMT), Brain Mapping Foundation, Pacific Palisades, Calif.
⁶ Society for Brain Mapping & Therapeutics, Los Angeles, CA; T-Neuro Pharma, Albuquerque, NM & Aptos, Calif.
⁷ Semmes Distinguished University Chair in Neurobiology, Department of Biology and Chemistry, University of Texas at San Antonio.
⁸ Society for Brain Mapping & Therapeutics, Mobile, Ala.
⁹ Zimmermann Professor of Neurology & Neurological Sciences, and Department of Pediatrics, Beckman Center for Molecular Medicine, Stanford University, Palo Alto, Calif.
¹⁰ Division of Neurosurgery, City of Hope National Medical Center, Duarte, Calif.
¹¹ Orthopaedic Surgery and Neurosurgery, University of Southern California, Los Angeles.
¹² Private Practice, Obstetrics and Gynecology, Athens, Ga.
¹³ Department of Psychiatry & Behavioral Sciences, Stanford University, Palo Alto, Calif.
¹⁴ VA Palo Alto Health Care System, Palo Alto, Calif; Department of Neurology, Stanford University, Palo Alto, Calif.
¹⁵ VA Palo Alto Health Care System, Palo Alto, Calif.
¹⁶ Society for Brain Mapping & Therapeutics, Los Angeles, CA.
¹⁷ USC Keck School of Medicine, Los Angeles, Calif.
¹⁸ Department of Medicine, The University of Arizona, Tucson.

PMID: 33198951
PMCID: PMC7583585
DOI: 10.1016/j.amjmed.2020.10.003

Editorial

MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness

J Wesson Ashford et al. Am J Med. 2021 Feb.

. 2021 Feb;134(2):153-155.

doi: 10.1016/j.amjmed.2020.10.003. Epub 2020 Oct 23.

Authors

Affiliations

¹ War Related Illness & Injury Study Center, VA Palo Alto Health Care System, Calif; Department of Psychiatry & Behavioral Sciences, Stanford University, Palo Alto, Calif. Electronic address: ashford@stanford.edu.
² World Organization, Watkinsville, Ga.
³ Grass Valley, Calif.
⁴ Stanford University School of Medicine, Palo Alto, Calif.
⁵ Society for Brain Mapping & Therapeutics (SBMT), Brain Mapping Foundation, Pacific Palisades, Calif.
⁶ Society for Brain Mapping & Therapeutics, Los Angeles, CA; T-Neuro Pharma, Albuquerque, NM & Aptos, Calif.
⁷ Semmes Distinguished University Chair in Neurobiology, Department of Biology and Chemistry, University of Texas at San Antonio.
⁸ Society for Brain Mapping & Therapeutics, Mobile, Ala.
⁹ Zimmermann Professor of Neurology & Neurological Sciences, and Department of Pediatrics, Beckman Center for Molecular Medicine, Stanford University, Palo Alto, Calif.
¹⁰ Division of Neurosurgery, City of Hope National Medical Center, Duarte, Calif.
¹¹ Orthopaedic Surgery and Neurosurgery, University of Southern California, Los Angeles.
¹² Private Practice, Obstetrics and Gynecology, Athens, Ga.
¹³ Department of Psychiatry & Behavioral Sciences, Stanford University, Palo Alto, Calif.
¹⁴ VA Palo Alto Health Care System, Palo Alto, Calif; Department of Neurology, Stanford University, Palo Alto, Calif.
¹⁵ VA Palo Alto Health Care System, Palo Alto, Calif.
¹⁶ Society for Brain Mapping & Therapeutics, Los Angeles, CA.
¹⁷ USC Keck School of Medicine, Los Angeles, Calif.
¹⁸ Department of Medicine, The University of Arizona, Tucson.

PMID: 33198951
PMCID: PMC7583585
DOI: 10.1016/j.amjmed.2020.10.003

No abstract available

PubMed Disclaimer

References

1. Yamamoto V, Bolanos JF, Fiallos J. COVID-19: review of a 21st century pandemic from etiology to neuro-psychiatric implications. J Alzheimers Dis. 2020;77(2):459–504. - PMC - PubMed
1. Gold JE, Tilley LP, Baumartil WH. MMR vaccine appears to confer strong protection from COVID-19: few deaths from SARS-CoV-2 in highly vaccinated populations. ResearchGate. 2020 https://www.researchgate.net/publication/341354165_MMR_Vaccine_Appears_t... Available at:
1. Franklin R, Young A, Neumann B. Homologous protein domains in SARS-CoV-2 and measles, mumps, and rubella viruses: preliminary evidence than MMR vaccine might provide protection against COVID-19. medRxiv. 2020 https://www.medrxiv.org/content/10.1101/2020.04.10.20053207v1.full.pdf Available at. - DOI
1. Ma C, Rodewald L, Hao L. Progress toward measles elimination - China, January 2013-June 2019. MMWR Morb Mortal Wkly Rep. 2019;68(48):1112–1116. - PMC - PubMed
1. Qian M, Chou SY, Lai EK. Confirmatory bias in health decisions: evidence from the MMR-autism controversy. J Health Econ. 2020;70 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness

Affiliations

MMR Vaccination: A Potential Strategy to Reduce Severity and Mortality of COVID-19 Illness

Authors

Affiliations

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical